Traws Pharma Inc (TRAW) support and resistance · rev $226.0K
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
This page maps Traws Pharma Inc (TRAW) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TRAW revenue for 2024-12-31 was $226.0K. Net income was -$166.5M. Revenue was up 0.0% from 2023-12-31 to 2024-12-31. TRAW currently screens at market cap $12.1M.
TRAW currently screens at market cap $12.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TRAW 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TRAW quote page for the session range and the stock page for the full model.
Not investment advice.